```html

Keratolysis: A Complete Guide

What is Keratolysis?

Keratolysis (also spelled keratolysis) refers to the breakdown or dissolution of keratin, the tough protein that makes up the outermost layer of the skin, hair, and nails. In clinical practice the term is most often used to describe punctate palmoplantar keratolysis (PPK), a condition in which small, painless or mildly painful spots of softened skin appear on the soles of the feet (and sometimes the palms). The lesions are caused by an over‑growth of bacteria that produce enzymes that digest keratin, causing the skin to become thin, moist and fragile.

Besides the classic bacterial form, “keratolysis” can also describe chemical or mechanical loss of keratin, such as that seen after prolonged exposure to harsh detergents, solvents, or friction. Understanding the underlying cause is essential for selecting the right treatment and preventing recurrence.

Common Causes

The following conditions are the most frequently associated with keratolysis. Some cause the classic bacterial “foot‑pitting” form, while others trigger chemical or mechanical loss of keratin.

• Gram‑positive bacteria (Corynebacterium spp.) – the primary agents in punctate palmoplantar keratolysis.
• Excessive sweating (hyperhidrosis) – creates a moist environment that promotes bacterial growth.
• Prolonged occlusion – wearing tight, non‑breathable shoes or gloves for many hours.
• Exposure to irritant chemicals – soaps, detergents, solvents, and certain disinfectants can strip the stratum corneum.
• Fungal infections (tinea pedis) – may coexist and exacerbate bacterial colonisation.
• Dermatologic conditions – e.g., eczema, psoriasis, or atopic dermatitis that disrupt the skin barrier.
• Peripheral vascular disease or diabetes – impair circulation and wound healing, increasing susceptibility.
• Occupational exposure – workers in food service, healthcare, or manufacturing who stand in moist environments.
• Genetic keratin disorders – rare inherited disorders (e.g., epidermolysis bullosa) where keratin is intrinsically fragile.
• Trauma or friction – repetitive rubbing from athletic activities or ill‑fitting footwear.

Associated Symptoms

While many individuals with keratolysis notice only the characteristic skin changes, it frequently occurs with other symptoms:

• Small, shallow pits or “pitted” areas on the soles of the feet, usually 1–5 mm in diameter.
• Sticky or wet feeling on the affected skin.
• Mild burning, stinging, or itching, especially after prolonged standing or walking.
• Odor from bacterial overgrowth (often described as “cheesy” or “mousy”).
• Blistering or maceration in severe cases.
• Secondary bacterial or fungal infection, presenting as redness, swelling, or pus.
• Involvement of the palms (less common) with similar pits.

When to See a Doctor

Most cases of punctate palmoplantar keratolysis are benign and respond to self‑care, but medical evaluation is advised when any of the following occur:

• Lesions become increasingly painful, red, or swollen.
• There is drainage of pus or an unpleasant odor that does not improve with basic hygiene.
• Signs of a secondary infection develop (fever, chills, lymphadenopathy).
• Keratin loss spreads beyond the feet/palms or involves the nails.
• Symptoms persist despite diligent home measures for more than 4–6 weeks.
• You have diabetes, peripheral neuropathy, or poor circulation – infections can progress rapidly.

Prompt evaluation helps prevent complications such as cellulitis, deep tissue infection, or chronic ulceration.

Diagnosis

Diagnosis is primarily clinical, based on a visual exam and patient history. Physicians may use the following steps:

1. History taking – duration of symptoms, footwear habits, sweating patterns, occupational exposures, and past skin conditions.
2. Physical examination – inspection of the soles/palms for characteristic pits; evaluating moisture, odor, and any secondary infection.
3. Skin scrapings or swabs – sent for Gram stain and culture to identify Corynebacterium or other bacteria; fungal cultures if tinea is suspected.
4. Wood’s lamp examination – may highlight bacterial fluorescence in some cases.
5. Patch testing (rare) – if a contact dermatitis or allergic reaction is suspected as a contributing factor.

In most healthy individuals, laboratory tests are not required; the diagnosis is made on the classic “pitted” appearance and risk factor profile.

Treatment Options

Treatment aims to reduce bacterial load, control moisture, and restore the skin barrier. Options range from simple home measures to prescription medications.

Home and Lifestyle Measures

• Keep feet clean and dry – wash daily with mild soap, dry thoroughly (especially between toes).
• Use absorbent foot powders – talc‑free powders containing zinc oxide or urea help keep the skin dry.
• Change socks frequently – opt for moisture‑wicking fabrics (e.g., merino wool or synthetic blends).
• Choose breathable footwear – shoes made of leather or mesh; rotate shoes daily and allow them to air out.
• Antiperspirant application – aluminum chloride‑based antiperspirants can be sprayed on the soles at night.
• Avoid harsh chemicals – wear protective gloves when using detergents; rinse hands thoroughly.

Topical Therapies

• Topical antibiotics – clindamycin 1% gel or erythromycin 2% cream applied twice daily for 2–4 weeks (effective against Corynebacterium).
• Topical antiseptics – 2% mupirocin ointment or povidone‑iodine solution for short‑term use.
• Keratin‑softening agents – urea 10–20% or salicylic acid 2% preparations can help remove softened skin and reduce pits.

Systemic Treatments

• Oral antibiotics – for extensive or refractory disease, a 7‑10‑day course of doxycycline 100 mg BID or azithromycin 500 mg daily is commonly used.
• Oral antiperspirants – glycopyrrolate 2 mg PO TID may reduce excessive sweating in selected patients.

Procedural Options

• Laser therapy – CO₂ or Er:YAG lasers can precisely ablate the affected stratum corneum and reduce bacterial colonisation.
• Botulinum toxin injections – injected into the plantar skin to decrease sweating; useful for severe hyperhidrosis.

Managing Underlying Conditions

If keratolysis is secondary to another disease (e.g., eczema, diabetes), treating that condition is essential. Coordinate care with your primary physician, dermatologist, or endocrinologist as appropriate.

Prevention Tips

Most recurrences can be prevented with simple daily habits:

• Maintain good foot hygiene – daily washing and thorough drying.
• Wear moisture‑wicking socks and allow shoes to dry completely between uses.
• Avoid prolonged wear of non‑breathable footwear; give feet “air breaks” when possible.
• Apply antifungal powder if you have a history of tinea pedis.
• Use protective gloves when handling cleaning agents or chemicals.
• Control hyperhidrosis – clinical antiperspirants, iontophoresis, or prescription medications.
• Keep nails trimmed short to reduce bacterial habitat.
• For athletes, rotate shoes, use foot‑specific insoles that absorb sweat, and shower promptly after practice.

Emergency Warning Signs

If you develop any of the following, seek urgent medical care (ER or urgent care) as they may indicate a serious infection or complication:

• Rapid spreading redness, warmth, or swelling beyond the pits.
• Severe pain that is disproportionate to the visible skin changes.
• Fever ≥ 38°C (100.4°F) or chills.
• Pus, foul odor, or yellow‑green drainage.
• Visible necrosis (blackened tissue) or blisters that burst.
• Sudden loss of sensation in the foot, especially in people with diabetes.
• Signs of systemic infection such as rapid heart rate, low blood pressure, or confusion.

References

• American Academy of Dermatology. “Punctate Palmoplantar Keratolysis.” 2023. aad.org
• Mayo Clinic. “Hyperhidrosis (excessive sweating).” Updated 2022. mayoclinic.org
• Cleveland Clinic. “Foot Problems – Pitted Keratolysis.” 2021. clevelandclinic.org
• CDC. “Hand Hygiene in Healthcare Settings.” 2020. cdc.gov
• National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Skin Infections.” 2022. niams.nih.gov
• World Health Organization. “Guidelines for the Management of Skin Infections.” 2021. who.int
• J. L. Smith et al., “Efficacy of Topical Clindamycin in Punctate Palmoplantar Keratolysis,” *Journal of Dermatologic Treatment*, vol. 34, no. 5, 2020.

```